Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.

Amir E, Seruga B, Niraula S, Carlsson L, OcaƱa A.

J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309. doi: 10.1093/jnci/djr242. Epub 2011 Jul 9. Review.

PMID:
21743022
2.

The influence of comorbidities on overall survival among older women diagnosed with breast cancer.

Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D.

J Natl Cancer Inst. 2011 Jul 20;103(14):1101-11. doi: 10.1093/jnci/djr188. Epub 2011 Jun 30.

3.

Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.

Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD.

Breast Cancer Res. 2011 Jun 20;13(3):R64. doi: 10.1186/bcr2901.

4.

Causes of death and relative survival of older women after a breast cancer diagnosis.

Schonberg MA, Marcantonio ER, Ngo L, Li D, Silliman RA, McCarthy EP.

J Clin Oncol. 2011 Apr 20;29(12):1570-7. doi: 10.1200/JCO.2010.33.0472. Epub 2011 Mar 14. Erratum in: J Clin Oncol. 2011 Sep 10;29(26):3594.

5.

Congestive heart failure risk in patients with breast cancer treated with bevacizumab.

Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, Bellmunt J, Burstein HJ, Schutz FA.

J Clin Oncol. 2011 Feb 20;29(6):632-8. doi: 10.1200/JCO.2010.31.9129. Epub 2011 Jan 4.

PMID:
21205755
6.

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW.

Lancet. 2011 Jan 1;377(9759):31-41. doi: 10.1016/S0140-6736(10)62110-1. Epub 2010 Dec 6.

PMID:
21144578
7.

Long-term prognostic role of functional limitations among women with breast cancer.

Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A, Melisko M, Esserman L, Weltzien EK, Caan BJ.

J Natl Cancer Inst. 2010 Oct 6;102(19):1468-77. doi: 10.1093/jnci/djq344. Epub 2010 Sep 22.

8.

Weight, physical activity, diet, and prognosis in breast and gynecologic cancers.

McTiernan A, Irwin M, Vongruenigen V.

J Clin Oncol. 2010 Sep 10;28(26):4074-80. doi: 10.1200/JCO.2010.27.9752. Epub 2010 Jul 19. Review.

9.

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ; American Society of Clinical Oncology.

J Clin Oncol. 2010 Aug 10;28(23):3784-96. doi: 10.1200/JCO.2009.26.3756. Epub 2010 Jul 12. Review.

PMID:
20625130
10.

Cancer statistics, 2010.

Jemal A, Siegel R, Xu J, Ward E.

CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):133-4.

11.

Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial.

Procter M, Suter TM, de Azambuja E, Dafni U, van Dooren V, Muehlbauer S, Climent MA, Rechberger E, Liu WT, Toi M, Coombes RC, Dodwell D, Pagani O, Madrid J, Hall M, Chen SC, Focan C, Muschol M, van Veldhuisen DJ, Piccart-Gebhart MJ.

J Clin Oncol. 2010 Jul 20;28(21):3422-8. doi: 10.1200/JCO.2009.26.0463. Epub 2010 Jun 7.

PMID:
20530280
12.
13.

Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.

Eagle KA, Ginsburg GS, Musunuru K, Aird WC, Balaban RS, Bennett SK, Blumenthal RS, Coughlin SR, Davidson KW, Frohlich ED, Greenland P, Jarvik GP, Libby P, Pepine CJ, Ruskin JN, Stillman AE, Van Eyk JE, Tolunay HE, McDonald CL, Smith SC Jr.

Circulation. 2010 Mar 30;121(12):1447-54. doi: 10.1161/CIRCULATIONAHA.109.904029. Review. No abstract available.

14.

Long-term survival of cancer patients compared to heart failure and stroke: a systematic review.

Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA, Debus J, Bischof M.

BMC Cancer. 2010 Mar 22;10:105. doi: 10.1186/1471-2407-10-105. Review.

15.

Screening for cardiovascular risk in asymptomatic patients.

Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS.

J Am Coll Cardiol. 2010 Mar 23;55(12):1169-77. doi: 10.1016/j.jacc.2009.09.066.

16.

Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.

Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA.

J Clin Oncol. 2010 Jan 20;28(3):380-6. doi: 10.1200/JCO.2009.23.5440. Epub 2009 Dec 14.

17.

Rethinking screening for breast cancer and prostate cancer.

Esserman L, Shieh Y, Thompson I.

JAMA. 2009 Oct 21;302(15):1685-92. doi: 10.1001/jama.2009.1498.

PMID:
19843904
18.

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M.

Lancet Oncol. 2009 May;10(5):501-7. doi: 10.1016/S1470-2045(09)70035-X. Review.

19.

A convenient tool to profile patients for generalized cardiovascular disease risk in primary care.

Wickramasinghe SR, DeFilippis AP, Lloyd-Jones DM, Blumenthal RS.

Am J Cardiol. 2009 Apr 15;103(8):1174-7. doi: 10.1016/j.amjcard.2008.12.040. Epub 2009 Feb 28.

PMID:
19361610
20.

Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors.

Ahern TP, Lash TL, Thwin SS, Silliman RA.

Med Care. 2009 Jan;47(1):73-9. doi: 10.1097/MLR.0b013e318180913c.

Supplemental Content

Support Center